Approach to the treatment of multiple myeloma: a clash of philosophies
Author:
Affiliation:
1. Division of Hematology, Mayo Clinic, Rochester, MN;
2. Karolinska Institutet, Huddinge, Stockholm, Sweden; and
3. Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/118/12/3205/1339853/zh803811003205.pdf
Reference56 articles.
1. Treatment of multiple myeloma.;Rajkumar;Nat Rev Clin Oncol,2011
2. Improved survival in multiple myeloma and the impact of novel therapies.;Kumar;Blood,2008
3. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma.;Kyle;Leukemia,2009
4. High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial.;Fermand;Blood,1998
5. Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.;Barlogie;J Clin Oncol,2006
Cited by 115 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Multiple myeloma: 2024 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2024-06-28
2. Adhesive capsaicin 8% patch for improved control of pain caused by chemotherapy-induced peripheral neuropathy in patients with multiple myeloma: A single-centre, seven-case series;Journal of Oncology Pharmacy Practice;2024-02-28
3. Multiple myeloma: challenges with deciding the optimal sequencing strategy;Frontiers in Pharmacology;2023-07-03
4. The Path Forward in Multiple Myeloma: 2021 Jan Waldenstrom Award Lecture;Clinical Lymphoma Myeloma and Leukemia;2022-09
5. Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee;Blood Cancer Journal;2022-06-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3